150 related articles for article (PubMed ID: 2837821)
21. [Value and indications for bronchoalveolar lavage combined with transbronchial lung biopsy].
Popper H; Pongratz M
Wien Klin Wochenschr; 1987 Dec; 99(24):848-55. PubMed ID: 3439184
[TBL] [Abstract][Full Text] [Related]
22. [Value of bronchoalveolar lavage in assessing the activity of sarcoidosis].
Christ R; Buchali K; Eckert H; Renner H; Sehrt I; Unger U
Z Erkr Atmungsorgane; 1987; 169(3):277-82. PubMed ID: 3445648
[TBL] [Abstract][Full Text] [Related]
23. Features of bronchoalveolar lavage differentiating hypersensitivity pneumonitis and pulmonary sarcoidosis at time of initial presentation.
Cantin A; Bégin R; Boileau R; Drapeau G; Rola-Pleszczynski M
Clin Invest Med; 1984; 7(2):89-94. PubMed ID: 6467702
[TBL] [Abstract][Full Text] [Related]
24. [Serum and urinary neopterin levels in sarcoidosis].
Terao I; Hagiwara T; Horie T
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jan; 31(1):1-6. PubMed ID: 8468809
[TBL] [Abstract][Full Text] [Related]
25. Does serum angiotensin converting enzyme reflect intensity of alveolitis in sarcoidosis?
Cohen RD; Bunting PS; Meindok HO; Chamberlain DW; Rebuck AS
Thorax; 1985 Jul; 40(7):497-500. PubMed ID: 2994247
[TBL] [Abstract][Full Text] [Related]
26. Unconjugated pteridines in bronchoalveolar lavage as indicators of alveolar macrophage activation.
Dhondt JL; Darras A; Mulliez P; Hayte JM; Crinquette J
Chest; 1989 Feb; 95(2):348-51. PubMed ID: 2914487
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of soluble CD 14 and neopterin as serum parameters of the inflammatory activity of pulmonary sarcoidosis.
Homolka J; Lorenz J; Zuchold HD; Müller-Quernheim J
Clin Investig; 1992 Oct; 70(10):909-16. PubMed ID: 1280495
[TBL] [Abstract][Full Text] [Related]
28. Value of enumerating cellular constituents of bronchoalveolar lavage fluid in differentiating sarcoidosis and cryptogenic fibrosing alveolitis.
Pande JN; Sharma SK; Verma K
Sarcoidosis; 1990 Sep; 7(2):96-100. PubMed ID: 2255801
[TBL] [Abstract][Full Text] [Related]
29. Involvement of the IP-10 chemokine in sarcoid granulomatous reactions.
Agostini C; Cassatella M; Zambello R; Trentin L; Gasperini S; Perin A; Piazza F; Siviero M; Facco M; Dziejman M; Chilosi M; Qin S; Luster AD; Semenzato G
J Immunol; 1998 Dec; 161(11):6413-20. PubMed ID: 9834133
[TBL] [Abstract][Full Text] [Related]
30. Lung inflammation in sarcoidosis: comparison of serum angiotensin-converting enzyme levels with bronchoalveolar lavage and gallium-67 scanning assessment of the T lymphocyte alveolitis.
Schoenberger CI; Line BR; Keogh BA; Hunninghake GW; Crystal RG
Thorax; 1982 Jan; 37(1):19-25. PubMed ID: 6280331
[TBL] [Abstract][Full Text] [Related]
31. Clinical and biochemical aspects of sarcoidosis. With special reference to angiotensin-converting enzyme (ACE).
Rømer FK
Acta Med Scand Suppl; 1984; 690():3-96. PubMed ID: 6097101
[TBL] [Abstract][Full Text] [Related]
32. Elevated levels of interferon gamma-inducible protein-10 and epithelial neutrophil-activating peptide-78 in patients with pulmonary sarcoidosis.
Sugiyama K; Mukae H; Ishii H; Kakugawa T; Ishimoto H; Nakayama S; Shirai R; Fujii T; Mizuta Y; Kohno S
Respirology; 2006 Nov; 11(6):708-14. PubMed ID: 17052298
[TBL] [Abstract][Full Text] [Related]
33. Generation of superoxide anion by alveolar macrophages in sarcoidosis: evidence for the activation of the oxygen metabolism in patients with high-intensity alveolitis.
Cassatella MA; Berton G; Agostini C; Zambello R; Trentin L; Cipriani A; Semenzato G
Immunology; 1989 Mar; 66(3):451-8. PubMed ID: 2539325
[TBL] [Abstract][Full Text] [Related]
34. [Cell and fluid permeability of the alveolar wall in sarcoidosis].
Fiser F; Helbich P; Kolarikova R; Striz I; Stulikova I; Prochazka J
Z Erkr Atmungsorgane; 1987; 169(3):269-76. PubMed ID: 2833038
[TBL] [Abstract][Full Text] [Related]
35. [Alveolitis in patients with sarcoidosis].
Tomić I; Dangubić V; Popović L; Colić M; Plavec G
Vojnosanit Pregl; 1992; 49(6):547-51. PubMed ID: 1297251
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory BAL-fluid and serum parameters in HLA DR17 positive vs. DR17 negative patients with pulmonary sarcoidosis.
Planck A; Eklund A; Grunewald J
Sarcoidosis Vasc Diffuse Lung Dis; 2001 Mar; 18(1):64-9. PubMed ID: 11354549
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary sarcoidosis: correlation of serum angiotensin-converting enzyme with blood and bronchoalveolar lymphocytes.
Rossman MD; Dauber JH; Cardillo ME; Daniele RP
Am Rev Respir Dis; 1982 Mar; 125(3):366-9. PubMed ID: 6279001
[TBL] [Abstract][Full Text] [Related]
38. Activity of angiotensin I converting enzyme in sarcoidosis, atopic bronchial asthma and acute bronchitis.
Plusa T; Chcialowski A; Piechota W; Pirozyński M
Allergol Immunopathol (Madr); 1990; 18(4):217-21. PubMed ID: 2176061
[TBL] [Abstract][Full Text] [Related]
39. Stage related morphometry of sarcoid granulomas and inflammatory cell types in broncho-alveolar lavage.
Kayser K; Hagemeyer O
Anal Cell Pathol; 1991 Nov; 3(6):335-42. PubMed ID: 1751400
[TBL] [Abstract][Full Text] [Related]
40. Extracellular matrix components in bronchoalveolar lavage fluid in sarcoidosis and their relationship to signs of alveolitis.
Blaschke E; Eklund A; Hernbrand R
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):1020-5. PubMed ID: 2327635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
